Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lisata Therapeutics (LSTA) Return on Assets (2016 - 2025)

Lisata Therapeutics' Return on Assets history spans 12 years, with the latest figure at 0.84% for Q4 2025.

  • For Q4 2025, Return on Assets fell 29.0% year-over-year to 0.84%; the TTM value through Dec 2025 reached 0.84%, down 29.0%, while the annual FY2025 figure was 0.63%, 18.0% down from the prior year.
  • Return on Assets reached 0.84% in Q4 2025 per LSTA's latest filing, down from 0.78% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.31% in Q2 2023 to a low of 0.84% in Q4 2025.
  • Average Return on Assets over 3 years is 0.52%, with a median of 0.49% recorded in 2024.
  • Peak YoY movement for Return on Assets: rose 4bps in 2024, then dropped -29bps in 2025.
  • A 3-year view of Return on Assets shows it stood at 0.37% in 2023, then plummeted by -48bps to 0.55% in 2024, then crashed by -54bps to 0.84% in 2025.
  • Per Business Quant, the three most recent readings for LSTA's Return on Assets are 0.84% (Q4 2025), 0.78% (Q3 2025), and 0.7% (Q2 2025).